查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790175

美國臨床實驗室服務市場規模、佔有率和趨勢分析（按測試類型、服務供應商、應用和細分預測），2025 年至 2033 年

U.S. Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type, By Service Provider, By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國臨床實驗室服務市場價值將達到 94.2 億美元，預計 2025 年至 2033 年複合年成長率為 5.07%。

這個市場主要受慢性病負擔日益加重的驅動，導致醫療保健機構對常規和專科診斷檢測的需求不斷成長。對早期診斷和預防性篩檢的日益重視，進一步加速了臨床實驗室服務的利用，尤其是針對糖尿病、心血管疾病和癌症等疾病。

此外，樣本檢測量的增加顯著改善了資料管理和樣本製備，從而實現了更有效率的檢測工作流程和更廣泛的檢測可用性。這些改進有助於實驗室縮短週轉時間，提高診斷準確性，並滿足各種醫療保健機構日益成長的需求。自動化系統數位化報告工具的整合也增強了業務能力，加快了結果獲取速度，並促進了臨床醫生和實驗室專業人員之間的更好協作。

市場也見證了新進入者日益成長的興趣，他們希望利用該行業的巨大潛力。例如，2023年2月，荷蘭生物技術公司Detact Diagnostics根據一份為期兩年的租賃協議，在基恩州立學院建立了一個新實驗室。同樣，2021年5月，Neuberg Diagnostics在美國推出了一個專門從事次世代定序（NGS）和分子診斷的實驗室——這些領域對精準醫療和早期疾病檢測至關重要。這些投資反映了專科檢測未來前景的不斷擴大，以及技術創新在塑造未來臨床實驗室服務方面日益重要的角色。

此外，不斷變化的法規環境和對基於價值的醫療服務的關注正在進一步影響美國臨床實驗室服務的發展。實驗室正日益努力滿足美國臨床實驗室改進協會 (CLIA) 和美國臨床病理學會 (CAP) 等組織制定的品質標準，以保持合規性並提高可靠性。同時，付款者強調成本效益和臨床效用，鼓勵實驗室採用更有針對性的檢測策略。這種轉變強化了對循證診斷的需求，這些診斷方法能夠支持臨床決策，並有助於改善患者預後並最佳化醫療保健支出。

在COVID-19疫情爆發之前，超過20萬家CLIA認證實驗室每年進行超過130億次臨床檢測，凸顯了診斷在醫療保健系統中的關鍵作用。根據美國慢性病主管協會的數據，截至2022年，美國近60%的人口將至少患有一種慢性病，而這些基礎設施在慢性病管理中發揮著至關重要的作用。隨著人口老化和預防保健的轉變，臨床對常規和專科檢測的需求只會不斷成長。

此次疫情進一步凸顯了診斷技術的關鍵作用。截至 2023 年 3 月，美國已進行了超過 11.7 億次 COVID-19 檢測。檢測能力的激增加強了公共衛生防範，並加速了對實驗室基礎設施的投資。新進業者，例如 2023 年 2 月在基恩州立學院建立實驗室的 Detact Diagnostics 和 2021 年 5 月在美國推出了次世代定序和分子診斷實驗室的 Neuberg Diagnostics，都在積極利用市場潛力。此外，ProPhase 參與企業於 2024 年 11 月宣布成立 DNA Complete, Inc.，這是一個直接面對消費者的 DNA 檢測平台，反映了市場對個人化診斷日益成長的趨勢。癌症發生率的上升（預計 2024 年新發病例將超過 200 萬）進一步刺激了對高級檢測服務（尤其是專門的腫瘤檢測）的持續需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國臨床實驗室服務市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國臨床實驗室服務市場的分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章：美國臨床實驗室服務市場（按測試類型、估計和趨勢分析）

  • 2024 年和 2033 年各測試類型的市場佔有率
  • 細分儀表板
  • 按測試類型分類的展望
  • 2021-2033 年市場規模、預測與趨勢分析
    • 基因檢測
    • 臨床化學
    • 醫學微生物學檢測
    • 血液檢查
    • 免疫學檢測
    • 細胞學檢查
    • 藥物濫用檢測
    • 其他

第5章：美國臨床實驗室服務市場（按服務供應商分類）、估計和趨勢分析

  • 2024 年及 2033 年服務供應商市場佔有率
  • 細分儀表板
  • 服務供應商展望
  • 2021-2033 年市場規模、預測與趨勢分析
    • 醫院附設實驗室
    • 獨立實驗室
    • 診所和實驗室

第6章：美國臨床實驗室服務市場的應用、估計與趨勢分析

  • 2024 年及 2033 年各應用領域的市場佔有率
  • 細分儀表板
  • 按用途展望
  • 2021-2033 年市場規模、預測與趨勢分析
    • 生物分析與實驗室化學服務
    • 毒理學測試服務
    • 細胞和基因治療相關服務
    • 臨床前和臨床試驗相關服務
    • 藥物發現及開發相關服務
    • 其他

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • LABORATORY CORPORATION OF AMERICA HOLDINGS（LABCORP）
    • Eurofins Scientific SE
    • QIAGEN NV
    • Quest Diagnostics Incorporated
    • OPKO HEALTH, INC.
    • Charles River Laboratories International, Inc.
    • ARUP LABORATORIES
    • Sonic Healthcare
    • Neogenomics Laboratories
    • Fresenius Medical Care
    • Siemens Medical Solutions USA, Inc.
    • SYNLAB International GmbH
    • Mayo Clinic Laboratories
    • Unilabs
Product Code: GVR-4-68040-670-3

Market Size & Trends:

The U.S. clinical laboratory services market size was estimated at USD 9.42 billion in 2024 and is projected to register a CAGR of 5.07% from 2025 to 2033. The market is primarily driven by the increasing burden of chronic diseases, which has intensified the demand for routine and specialized diagnostic testing across care settings. Rising emphasis on early diagnosis and preventive screening has further accelerated the use of clinical laboratory services, particularly for conditions such as diabetes, cardiovascular disorders, and cancer.

In addition, the growing volume of sample testing has led to notable improvements in data management and sample preparation, supporting more efficient laboratory workflows and broader test availability. These enhancements are helping laboratories reduce turnaround times, improve diagnostic accuracy, and handle rising demand across various healthcare settings. Integration of automated systems and digitized reporting tools is also strengthening operational capacity, enabling faster delivery of results and better coordination between clinicians and lab professionals.

The market is also witnessing growing interest from new entrants aiming to capitalize on the sector's strong potential. Driven by the sector's lucrative prospects, new entrants are actively investing in the U.S. For instance, in February 2023, Dutch biotech firm Detact Diagnostics established a new laboratory at Keene State College under a two-year rental agreement. Similarly, in May 2021, Neuberg Diagnostics launched a U.S. lab focused on next-generation sequencing (NGS) and molecular diagnostics-key areas for precision medicine and early disease detection. These investments reflect the expanding scope of specialized testing and the increasing role of innovation in shaping future clinical laboratory services.

Moreover, the evolving regulatory environment and focus on value-based care are further influencing the development of clinical laboratory services in the U.S. Laboratories are increasingly aligning with quality standards set by organizations such as CLIA and CAP to maintain compliance and enhance credibility. At the same time, payers' emphasis on cost-effectiveness and clinical utility encourages labs to adopt more targeted testing strategies. This shift reinforces the need for evidence-backed diagnostics that support clinical decision-making and contribute to improved patient outcomes and optimized healthcare spending.

Prior to the COVID-19 pandemic, over 13 billion clinical tests were conducted annually across more than 200,000 CLIA-certified laboratories, highlighting the essential role of diagnostics in the healthcare system. This infrastructure plays a key role in managing chronic conditions, with nearly 60% of the U.S. population living with at least one chronic disease as of 2022, according to the National Association of Chronic Disease Directors. The clinical demand for routine and specialized testing continues to rise with the country's aging population and the shift toward preventive care.

The pandemic further underscored the critical role of diagnostics, with over 1.17 billion COVID-19 tests performed in the U.S. by March 2023. This surge in testing capacity has strengthened public health preparedness and accelerated investment in lab infrastructure. New entrants are actively tapping into the market's potential, such as Detact Diagnostics, which established a laboratory at Keene State College in February 2023, and Neuberg Diagnostics, which launched a U.S. lab for next-generation sequencing and molecular diagnostics in May 2021. In addition, ProPhase Labs introduced DNA Complete, Inc. in November 2024, a direct-to-consumer DNA testing platform reflecting the market's growing orientation toward personalized diagnostics. Rising cancer incidence-projected to exceed 2 million new cases in 2024-further reinforces the ongoing demand for advanced laboratory services, particularly in oncology-focused testing.

U.S. Clinical Laboratory Services Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. clinical laboratory services market report based on test type,application, and service provider:

  • Test Type Outlook (Revenue in USD Million, 2021 - 2033)
  • Genetic Testing
  • Clinical Chemistry
    • Routine Chemistry Testing
    • Therapeutic Drug Monitoring Testing
    • Endocrinology Chemistry Testing
    • Specialized Chemistry Testing
    • Other Clinical Chemistry Testing
  • Medical Microbiology Testing
    • Infectious Disease Testing
    • Transplant Diagnostic Testing
    • Other Microbiology Testing
  • Hematology Testing
  • Immunology Testing
  • Cytology Testing
  • Drug of Abuse Testing
  • Other Esoteric Tests
  • Service Provider Outlook (Revenue in USD Million, 2021 - 2033)
  • Hospital-Based Laboratories
  • Stand-Alone Laboratories
  • Clinic-Based Laboratories
  • Application Outlook (Revenue in USD Million, 2021 - 2033)
  • Bioanalytical & Lab Chemistry Services
  • Toxicology Testing Services
  • Cell & Gene Therapy Related Services
  • Preclinical & Clinical Trial Related Services
  • Drug Discovery & Development Related Services
  • Other Clinical Laboratory Services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Service Provider
    • 1.2.3. Application
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Service Provider outlook
    • 2.2.3. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Clinical Laboratory Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in the field of clinical testing
      • 3.2.1.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
      • 3.2.1.3. Introduction of novel solutions
      • 3.2.1.4. Outbreak of COIVD-19 pandemic
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent regulatory framework
  • 3.3. U.S. Clinical laboratory services market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Clinical laboratory services market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. U.S. Clinical laboratory services market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Genetic Testing
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Clinical Chemistry
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Medical Microbiology Testing
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Hematology Testing
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Immunology Testing
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.6. Cytology Testing
      • 4.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.7. Drug of Abuse Testing
      • 4.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.8 Other Esoteric Tests
      • 4.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis

  • 5.1. Service Provider Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. U.S. Clinical laboratory services market by Service Provider Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Hospital-Based Laboratories
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Stand-Alone Laboratories
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Clinic-Based Laboratories
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Clinical Laboratory Services Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. U.S. Clinical laboratory services market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Bioanalytical & Lab Chemistry Services
      • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Toxicology Testing Services
      • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Cell & Gene Therapy Related Services
      • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Preclinical & Clinical Trial Related Services
      • 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Drug Discovery & Development Related Services
      • 6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Eurofins Scientific SE
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QIAGEN NV
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quest Diagnostics Incorporated
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. OPKO HEALTH, INC.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Charles River Laboratories International, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. ARUP LABORATORIES
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Sonic Healthcare
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Neogenomics Laboratories
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Fresenius Medical Care
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Siemens Medical Solutions USA, Inc.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. SYNLAB International GmbH
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Mayo Clinic Laboratories
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Unilabs
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. Clinical laboratory services market, by test type, 2021 - 2033 (USD Million)
  • Table 3 U.S. Clinical laboratory services market, by service provider, 2021 - 2033 (USD Million)
  • Table 4 U.S. Clinical laboratory services market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in U.S.
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. clinical laboratory services market: market outlook
  • Fig. 10 U.S. clinical laboratory services competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Clinical laboratory services market driver impact
  • Fig. 16 U.S. Clinical laboratory services market restraint impact
  • Fig. 17 U.S. Clinical laboratory services market strategic initiatives analysis
  • Fig. 18 U.S. Clinical laboratory services market: Test Type movement analysis
  • Fig. 19 U.S. Clinical laboratory services market: Test Type outlook and key takeaways
  • Fig. 20 Genetic Testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Clinical chemistry market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 22 Routine chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 23 Therapeutic drug monitoring testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 24 Endocrinology chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 25 Specialized chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 26 Other clinical chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 27 Medical microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 28 Infectious disease testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 29 Transplant diagnostic testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 30 Other microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 31 Hematology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 32 Immunology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 33 Cytology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 34 Drug of abuse testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 35 Other esoteric tests market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Clinical laboratory services market: Service Provider movement Analysis
  • Fig. 37 U.S. Clinical laboratory services market: Service Provider outlook and key takeaways
  • Fig. 38 Hospital-based laboratories market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 39 Stand-alone laboratories market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 40 Clinic-based laboratories market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Clinical laboratory services market: application movement analysis
  • Fig. 42 U.S. Clinical laboratory services market: application outlook and key takeaways
  • Fig. 43 Bioanalytical & lab chemistry services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 44 Toxicology testing services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 45 Cell & gene therapy related services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 46 Preclinical & clinical trial related services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 47 Drug discovery & development related services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 48 Other U.S. Clinical laboratory services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Clinical laboratory services market share and leading players
  • Fig. 50 U.S. market share and leading players
  • Fig. 51 U.S. SWOT
  • Fig. 52 U.S. market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 53 Market share of key market players - U.S. Clinical laboratory services market